Interestingly, it was found that free G3139 triggered mild tumor suppression during the first two weeks of treatment, which could not be explained by its antisense mechanism since no corresponding Bcl-2 reduction was observed in free G3139-treated tumors (Figure 6). This evidence concerns the gene BCL2 and neoplasm.